Overview

Definition:
-Transjugular intrahepatic portosystemic shunt (TIPS) is a minimally invasive procedure performed by interventional radiologists to create a tract between the portal vein and a hepatic vein within the liver
-This reduces portal pressure, thereby controlling complications of portal hypertension
-The surgical interface refers to the critical aspects relevant to surgeons, including indications, potential complications, and the role of surgical intervention in specific scenarios related to TIPS.
Epidemiology:
-Portal hypertension affects millions globally, with conditions like cirrhosis being a primary driver
-TIPS is indicated in a significant subset of these patients who develop refractory ascites, recurrent variceal bleeding, or hepatorenal syndrome
-The incidence of TIPS procedures has steadily increased with advancements in interventional radiology.
Clinical Significance:
-For surgeons, understanding TIPS is crucial as it directly impacts the management of patients with end-stage liver disease
-It serves as a bridge to liver transplantation, a potential treatment for otherwise intractable complications, and can necessitate surgical intervention for its own complications or when it fails
-It represents a paradigm shift from open surgical shunts to percutaneous, image-guided interventions.

Indications

Primary Indications:
-Management of refractory ascites unresponsive to medical therapy
-Prevention of variceal rebleeding in high-risk patients
-Management of hepatorenal syndrome (HRS) as a bridge to transplantation.
Secondary Indications:
-Management of hepatopulmonary syndrome (HPS) and platypnea-orthodeoxia syndrome
-Relief of Budd-Chiari syndrome
-Control of refractory hepatic hydrothorax.
Contraindications:
-Severe hepatic encephalopathy refractory to medical management
-Primary sclerosing cholangitis with dominant biliary strictures
-Congenital absence of hepatic veins
-Untreated severe sepsis or cholangitis
-Severe pulmonary hypertension (mean PAP > 50 mmHg)
-Cardiac failure.

Preoperative Preparation

Patient Evaluation:
-Thorough assessment of liver function (Child-Pugh score, MELD score)
-Evaluation for comorbidities, especially cardiac and pulmonary function
-Detailed assessment of ascites, variceal status, and hepatic encephalopathy severity
-Endoscopic evaluation for varices is mandatory.
Imaging:
-Abdominal ultrasound with Doppler to assess portal vein patency and direction of flow
-CT angiography or MR angiography for detailed venous anatomy and potential anatomical variations
-Doppler ultrasound of the hepatic veins and IVC.
Medical Optimization:
-Diuretic therapy for ascites management
-Beta-blockers for variceal prophylaxis
-Lactulose and/or rifaximin for hepatic encephalopathy management
-Nutritional assessment and support
-Prophylactic antibiotics in patients with increased risk of infection.

Procedure Overview And Surgical Relevance

Procedure Steps:
-Under local anesthesia, an introducer sheath is placed in the right internal jugular vein
-A guidewire is advanced into the hepatic vein
-A needle is used to puncture the hepatic vein parenchyma and enter a portal venous radical
-A tract is created and dilated, followed by stent-graft deployment between the hepatic vein and portal vein branches
-Angiographic confirmation of shunt patency and pressure measurement are performed.
Surgical Role In Placement:
-While primarily an interventional radiology procedure, surgeons are involved in the multidisciplinary team
-They may be consulted for complex cases, particularly those with anatomical challenges or when surgical alternatives are considered
-Surgeons manage patients pre- and post-TIPS and are involved in the care of TIPS-related complications.
Stent Graft Considerations:
-The choice of stent graft material (e.g., PTFE-covered stents) is crucial to minimize endothelialization and subsequent thrombosis, thus maintaining patency
-Stent diameter and length are chosen based on anatomical considerations and desired pressure reduction.

Postoperative Care And Monitoring

Immediate Postoperative Care:
-Monitoring of vital signs, hematocrit, and electrolytes
-Pain management
-Strict fluid balance monitoring
-Close observation for signs of bleeding, infection, or shunt dysfunction.
Monitoring For Dysfunction:
-Regular Doppler ultrasound to assess shunt velocity and patency
-Measurement of portosystemic gradient (PSG) via TIPS venography or hepatic vein pressure measurement every 6-12 months
-Serial liver function tests and assessment for ascites and encephalopathy.
Medical Management Post Tips:
-Continued diuretic therapy if ascites persists
-Maintenance of lactulose/rifaximin for encephalopathy
-Antibiotic prophylaxis may be continued in select patients
-Antithrombotic therapy (e.g., aspirin) is usually initiated to maintain shunt patency.

Complications

Early Complications:
-Hemorrhage (from access site or intrahepatic injury)
-Shunt thrombosis or stenosis
-Hepatic artery injury
-Hepatic vein stenosis or thrombosis
-Bile duct injury
-Sepsis
-Fluid overload
-Worsening hepatic encephalopathy.
Late Complications:
-Shunt stenosis or thrombosis (most common)
-Hepatic encephalopathy (can be de novo or worsened)
-Progressive liver dysfunction
-Shunt infection
-Shunt migration or erosion
-Portal vein thrombosis.
Surgical Management Of Complications:
-Surgical intervention may be required for refractory shunt dysfunction unresponsive to balloon angioplasty, for shunt thrombosis leading to re-bleeding or decompensation, or for complications like shunt erosion or infection
-Surgical options include revision angioplasty, thrombectomy, shunt revision, or, in some cases, liver transplantation
-Open surgical shunts are rarely considered now.

Prognosis

Factors Affecting Prognosis:
-Severity of underlying liver disease (MELD score, Child-Pugh class)
-Technical success and initial shunt patency
-Presence and severity of hepatic encephalopathy
-Development of shunt dysfunction or thrombosis
-Development of infections.
Outcomes With Treatment:
-Successful TIPS placement can significantly reduce portal pressure, control variceal bleeding, and improve ascites
-It can improve quality of life and serve as a bridge to transplantation
-However, it does not cure the underlying liver disease.
Follow Up And Transplantation Considerations:
-Regular follow-up is essential to monitor shunt patency and manage complications
-For patients with end-stage liver disease, TIPS can improve their status and suitability for liver transplantation
-Surgeons play a key role in the transplant evaluation and peri-transplant management of these patients.

Key Points

Exam Focus:
-Indications for TIPS, contraindications, and common complications
-The role of TIPS in managing refractory ascites and variceal bleeding
-Management of hepatic encephalopathy post-TIPS
-Understanding shunt patency monitoring and when surgical intervention is needed.
Clinical Pearls:
-Always consider TIPS in patients with decompensated cirrhosis and complications refractory to medical management
-Aggressive management of hepatic encephalopathy is crucial post-TIPS
-Early recognition of shunt dysfunction is key to preventing re-bleeding or decompensation.
Common Mistakes:
-Incorrectly identifying contraindications
-Failure to optimize medical management prior to TIPS
-Inadequate monitoring of shunt patency
-Underestimating the risk or severity of hepatic encephalopathy
-Delaying surgical consultation for refractory complications.